JSP: Lannett loses Jerome Stevens Pharmaceuticals supplier deal
Jerome Stevens Pharmaceuticals broke off its distribution deal with Lannett for butalbital, aspirin, caffeine with codeine phosphate capsules, digoxin tablets and levothyroxine sodium tablets. Read More
Read full article »
CEO
JSP is a pharmaceutical company that develops and commercializes drugs for the treatment of thyroid tumors.
Read more